These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Frey BN; Andreazza AC; Houenou J; Jamain S; Goldstein BI; Frye MA; Leboyer M; Berk M; Malhi GS; Lopez-Jaramillo C; Taylor VH; Dodd S; Frangou S; Hall GB; Fernandes BS; Kauer-Sant'Anna M; Yatham LN; Kapczinski F; Young LT Aust N Z J Psychiatry; 2013 Apr; 47(4):321-32. PubMed ID: 23411094 [TBL] [Abstract][Full Text] [Related]
3. Peripheral biomarkers and illness activity in bipolar disorder. Kapczinski F; Dal-Pizzol F; Teixeira AL; Magalhaes PV; Kauer-Sant'Anna M; Klamt F; Moreira JC; de Bittencourt Pasquali MA; Fries GR; Quevedo J; Gama CS; Post R J Psychiatr Res; 2011 Feb; 45(2):156-61. PubMed ID: 20541770 [TBL] [Abstract][Full Text] [Related]
10. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Kapczinski F; Dias VV; Kauer-Sant'Anna M; Brietzke E; Vázquez GH; Vieta E; Berk M Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1366-71. PubMed ID: 19666076 [TBL] [Abstract][Full Text] [Related]
11. [Can we identify biomarkers in bipolar depression? From imaging to biology]. Leboyer M; Fossati P Encephale; 2011 Dec; 37 Suppl 3():S185-90. PubMed ID: 22212873 [TBL] [Abstract][Full Text] [Related]
12. Corticolimbic connectivity as a possible biomarker for bipolar disorder. Vai B; Bollettini I; Benedetti F Expert Rev Neurother; 2014 Jun; 14(6):631-50. PubMed ID: 24852228 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers and staging of bipolar disorder: a systematic review. Roda Â; Chendo I; Kunz M Trends Psychiatry Psychother; 2015; 37(1):3-11. PubMed ID: 25860561 [TBL] [Abstract][Full Text] [Related]
14. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453 [TBL] [Abstract][Full Text] [Related]
15. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Rowland T; Perry BI; Upthegrove R; Barnes N; Chatterjee J; Gallacher D; Marwaha S Br J Psychiatry; 2018 Sep; 213(3):514-525. PubMed ID: 30113291 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers for bipolar disorder: current status and challenges ahead. Teixeira AL; Colpo GD; Fries GR; Bauer IE; Selvaraj S Expert Rev Neurother; 2019 Jan; 19(1):67-81. PubMed ID: 30451546 [TBL] [Abstract][Full Text] [Related]
17. Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application. Rege S; Hodgkinson SJ Aust N Z J Psychiatry; 2013 Dec; 47(12):1136-51. PubMed ID: 23908311 [TBL] [Abstract][Full Text] [Related]
18. Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder. Frey BN; Dias RS Bipolar Disord; 2014 Feb; 16(1):48-57. PubMed ID: 24206266 [TBL] [Abstract][Full Text] [Related]
19. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI? Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374 [TBL] [Abstract][Full Text] [Related]
20. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Gama CS; Kunz M; Magalhães PV; Kapczinski F Braz J Psychiatry; 2013 Mar; 35(1):70-4. PubMed ID: 23567604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]